Ligand profile
CHEMBL4532317
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_03018 — Imidazolonepropionase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL4532317- UniProt (similar protein)
Q81WF0- Target protein
- KP13_03018
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 57.7
- −1 ≤ LogP ≤ 5 1.71
- MW ≤ 500 Da 296.4
- LogP ≤ 5 1.71
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 57.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCS(=O)(=O)N(C)c1ccc(C(=O)N2CCCC2)cc1CCS(=O)(=O)N(C)c1ccc(C(=O)N2CCCC2)cc1
InChI=1S/C14H20N2O3S/c1-3-20(18,19)15(2)13-8-6-12(7-9-13)14(17)16-10-4-5-11-16/h6-9H,3-5,10-11H2,1-2H3InChI=1S/C14H20N2O3S/c1-3-20(18,19)15(2)13-8-6-12(7-9-13)14(17)16-10-4-5-11-16/h6-9H,3-5,10-11H2,1-2H3
OKTWLIQYCHYGIT-UHFFFAOYSA-NOKTWLIQYCHYGIT-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Activity
- Active
- Binding sites
- PF01979
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL4532317 →
- UniProt UniProt Q81WF0 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL4532317”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03018.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).